Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 3,4-Diaminopyridine (DAP) in the treatment of Lambert-Eaton myasthenic syndrome (LEMS).

× No keyword cloud information.

11 in total

1. Paraneoplastic Diseases of the Nervous System.

Authors:
Journal: Curr Treat Options Neurol Date: 1999-11 Impact factor: 3.598

Review 2. Lambert-Eaton myasthenic syndrome.

Authors: U Seneviratne; R de Silva
Journal: Postgrad Med J Date: 1999-09 Impact factor: 2.401

Review 3. Presynaptic Deficits at Neuromuscular Junctions: A Specific Cause and Potential Target of Axonal Neuropathy in Type 2 Charcot-Marie-Tooth Disease.

Authors: Gursimran Chandhok; Ming Shiuan Soh
Journal: J Neurosci Date: 2016-08-03 Impact factor: 6.167

4. Symptomatic treatment of botulism with a clinically approved small molecule.

Authors: Edwin Vazquez-Cintron; James Machamer; Celinia Ondeck; Kathleen Pagarigan; Brittany Winner; Paige Bodner; Kyle Kelly; M Ross Pennington; Patrick McNutt
Journal: JCI Insight Date: 2020-01-30

5. 3,4-diaminopyridine safety in clinical practice: an observational, retrospective cohort study.

Authors: Laurent Flet; Elisabeth Polard; Olivia Guillard; Emmanuelle Leray; Hervé Allain; Loïc Javaudin; Gilles Edan
Journal: J Neurol Date: 2010-01-08 Impact factor: 4.849

Review 6. Ca2+ channels as targets of neurological disease: Lambert-Eaton Syndrome and other Ca2+ channelopathies.

Authors: Michael T Flink; William D Atchison
Journal: J Bioenerg Biomembr Date: 2003-12 Impact factor: 2.945

7. Update on treatment options for Lambert-Eaton myasthenic syndrome: focus on use of amifampridine.

Authors: Sabine Lindquist; Martin Stangel
Journal: Neuropsychiatr Dis Treat Date: 2011-05-30 Impact factor: 2.570

8. 4-aminopyridine does not enhance flocculus function in tottering, a mouse model of vestibulocerebellar dysfunction and ataxia.

Authors: John S Stahl; Zachary C Thumser
Journal: PLoS One Date: 2013-02-25 Impact factor: 3.240

9. Use-dependent potentiation of voltage-gated calcium channels rescues neurotransmission in nerve terminals intoxicated by botulinum neurotoxin serotype A.

Authors: Phillip H Beske; Katie M Hoffman; James B Machamer; Margaret R Eisen; Patrick M McNutt
Journal: Sci Rep Date: 2017-11-20 Impact factor: 4.379

10. Population Pharmacokinetics/Pharmacodynamics of 3,4-Diaminopyridine Free Base in Patients With Lambert-Eaton Myasthenia.

Authors: Nilay Thakkar; Jeffrey T Guptill; Kathy Aleš; David Jacobus; Laura Jacobus; Charles Peloquin; Michael Cohen-Wolkowiez; Daniel Gonzalez
Journal: CPT Pharmacometrics Syst Pharmacol Date: 2017-07-24